News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mistral Pharma Inc. Launches INSTILLAGEL(R) on the Canadian Market


11/1/2007 10:11:06 AM

MONTREAL, QUEBEC--(Marketwire - November 01, 2007) - Mistral Pharma Inc. (TSX VENTURE: MIP) ("Mistral") today announced that it is launching INSTILLAGEL® on the Canadian market. INSTILLAGEL® is now available to all urology clinics, hospitals and pharmacies across Canada. INSTILLAGEL® is a sterile gel containing lidocaine 2% and chlorhexidine 0,05% and is indicated for surface anaesthesia, lubrication and antisepsis for the male and female urethra during cytoscopy, catheterization, exploration by sound and other endourethral operations.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES